Related Experiment Video
Updated: Jun 19, 2026
06:40
Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
Published on: January 25, 2018
NSAID-derived gamma-secretase modulators. Part III: Membrane anchoring
Stefanie Baumann1, Nicole Höttecke, Robert Schubenel
1Clemens Schöpf-Institute of Chemistry and Biochemistry, Technische Universität Darmstadt, Petersenstr. 22, D-64287 Darmstadt, Germany.
Bioorganic & Medicinal Chemistry Letters
|November 3, 2009
Summary
Researchers developed novel small-molecule gamma-secretase modulators (sGSMs) to reduce amyloid-beta 42 (Abeta(42)) levels, a key target for Alzheimer's disease therapy. Seven compounds showed promising activity, offering potential new treatments for this neurodegenerative condition.
Area of Science:
- Neuroscience
- Medicinal Chemistry
- Pharmacology
Background:
- Alzheimer's disease (AD) is characterized by the accumulation of amyloid-beta (Abeta) peptides, particularly Abeta(42).
- Selective lowering of Abeta(42) using small-molecule gamma-secretase modulators (sGSMs) is a promising therapeutic strategy.
- Some non-steroidal anti-inflammatory drugs (NSAIDs) exhibit sGSM activity.
Purpose of the Study:
- To synthesize and evaluate novel N-substituted carbazole- and O-substituted fenofibrate-derived sGSMs.
- To assess the efficacy of these compounds in reducing Abeta(42) secretion.
Main Methods:
- Synthesis of novel carbazole and fenofibrate derivatives.
- Screening of 19 compounds for activity against Abeta(42) secretion.
- In vitro assays to determine compound efficacy at low micromolar levels.
Main Results:
- Seven out of 19 screened compounds demonstrated significant activity against Abeta(42) secretion.
- Promising activity was observed at low micromolar concentrations.
- The study proposes a mechanism involving interaction with Lys624 and membrane anchoring via lipophilic substituents.
Conclusions:
- Novel sGSMs based on carbazole and fenofibrate scaffolds show potential for Alzheimer's disease therapy.
- The identified compounds effectively reduce Abeta(42) levels.
- Further investigation into the interaction mechanism may guide future drug design.
Related Concept Videos
01:32Lipids as Anchors
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
01:29GPI Anchoring of Proteins in the ER Membrane
GPI-anchoring is a post-translational, reversible protein modification that is ubiquitous in eukaryotes. Such proteins are primarily present on the exoplasmic leaflet of the plasma membrane.
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
01:45Tail-anchoring of Proteins in the ER Membrane
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
01:11IP3/DAG Signaling Pathway
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
01:45Regulation of Nuclear Protein Sorting
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.